USChina AI Industry Competitive and Intellectual Property Dispute Update ORIQ Origin CEO highlights planned portfolio diversification in comments accompanying latest quarterly earnings VET Vermilion Q4 2025 EPS lands far below estimates shares dip 088 percent on weak results DBGI DigiBrands falls 592 after Q3 2023 earnings release with no consensus estimates for key financial metrics Vertex Pharmaceuticals Incorporated VRTX Price Target Raised by RBC Amid Positive Regulatory Milestones and Biotech Sector Tailwinds SMTI Sanara MedTech climbs 25 percent in daily trading despite Q4 2025 EPS landing below analyst estimates EastGroup Properties EGP Stock Risk Q1 2026 EPS Beats Forecasts